Jubilant Therapeutics

Bedminster, United States Founded: 2019 • Age: 7 yrs
Develops innovative small molecule drugs for oncology and autoimmune diseases.

About Jubilant Therapeutics

Jubilant Therapeutics is a company based in Bedminster (United States) founded in 2019. It operates as a B2B. Jubilant Therapeutics operates in a competitive market with competitors including Moderna, Horizon Therapeutics, Forge Biologics, argenx and Sana Biotechnology, among others.

  • Headquarter Bedminster, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Jubilant Therapeutics
Headcount 1-10
Employee Profiles 5
Board Members and Advisors 12
Employee Profiles
People
Daniel J. O'Connor
CEO
People
Agunan Krishnan
Director Of Business Development
People
Shyam Pattabiraman
VP & CFO
People
Melda Dolan
Chief Medical Officer

Unlock access to complete

Board Members and Advisors
people
Ron Christopher
Advisor
people
William Lambert
Advisor
people
Arvind Chokhany
Director
people
Hari S Bhartia
Director

Unlock access to complete

Funding Insights of Jubilant Therapeutics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investments & Acquisitions by Jubilant Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Jubilant Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jubilant Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Jubilant Therapeutics

Jubilant Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Horizon Therapeutics, Forge Biologics, argenx and Sana Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
mRNA-based therapeutics for diseases including cancer and infections are developed.
domain founded_year HQ Location
Developer of drugs for treating rare and autoimmune diseases
domain founded_year HQ Location
Gene therapies for rare diseases are developed to treat patients.
domain founded_year HQ Location
Antibody-based drugs are developed for autoimmune diseases and cancer treatment.
domain founded_year HQ Location
Genetically engineered cell therapies are developed for multiple disorders.
domain founded_year HQ Location
Developer of antibodies to treat complement-mediated neurodegenerative diseases
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Jubilant Therapeutics

When was Jubilant Therapeutics founded?

Jubilant Therapeutics was founded in 2019.

Where is Jubilant Therapeutics located?

Jubilant Therapeutics is headquartered in Bedminster, United States. It is registered at Bedminster, New Jersey, United States.

What does Jubilant Therapeutics do?

Jubilant Therapeutics, founded in 2019 in Bedminster, United States, focuses on providing healthcare solutions, advancing biotech innovations, drug development, and oncology and autoimmune therapies. Develops innovative small molecule drugs for oncology and autoimmune diseases. The company is dedicated to excellence, innovation, and customer satisfaction, ensuring sustainable practices and long-term success in its sectors.

Who are the top competitors of Jubilant Therapeutics?

Jubilant Therapeutics's top competitors include Moderna, argenx and Forge Biologics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available